Leuprorelin (Leuprolide) EP Impurity H is a structural variant used to benchmark analytical specificity in leuprolide testing. Its altered sequence influences chromatographic mobility and solution conformation. Researchers rely on it for impurity quantification and structural verification. Applications include process development, stability testing, and LC-MS method refinement.
CAT No: Z10-101-197
Synonyms/Alias:(S)-N-ethyl-1-(((S)-5-oxopyrrolidine-2-carbonyl)-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-D-leucyl-L-arginyl)pyrrolidine-2-carboxamide
Leuprorelin (Leuprolide) EP Impurity H is a specialized peptide impurity associated with the synthesis and quality assessment of leuprorelin, a well-known gonadotropin-releasing hormone (GnRH) analog. As a structurally related compound, this impurity is of significant interest in pharmaceutical research and analytical development. Its unique peptide sequence and close resemblance to the parent molecule make it an essential reference standard in various laboratory settings. Leuprorelin (Leuprolide) EP Impurity H is commonly utilized in advanced analytical applications, supporting the need for stringent quality control and method validation in peptide-based drug manufacturing. Researchers value its availability for ensuring the specificity, accuracy, and robustness of analytical procedures, especially in the context of impurity profiling and stability studies. The compound's role extends beyond simple quality checks, contributing to a deeper understanding of peptide degradation pathways and the overall behavior of leuprorelin formulations under various conditions.
Pharmaceutical Quality Control: Leuprorelin (Leuprolide) EP Impurity H plays a pivotal role in the quality control of peptide pharmaceuticals. Analytical laboratories employ this impurity as a reference standard during high-performance liquid chromatography (HPLC) and mass spectrometry analyses to detect, quantify, and monitor trace levels of related substances in leuprorelin drug substances and finished products. By comparing retention times and spectral data, scientists can accurately differentiate between the active pharmaceutical ingredient and its associated impurities, ensuring the consistency and safety of peptide medications throughout production and storage.
Analytical Method Development and Validation: In the development and validation of analytical methods for peptide drugs, Leuprorelin Impurity H serves as a critical tool. Its inclusion in method validation studies allows researchers to evaluate the selectivity, sensitivity, and reproducibility of chromatographic and spectrometric techniques. By challenging analytical systems with structurally similar impurities, laboratories can optimize separation parameters and confirm the reliability of their methods for routine batch release and stability testing. This approach is vital for meeting the rigorous demands of modern pharmaceutical analysis.
Impurity Profiling and Characterization: The use of Leuprorelin (Leuprolide) EP Impurity H is integral to comprehensive impurity profiling in peptide drug development. Researchers utilize this compound to identify and characterize potential degradation products that may arise during synthesis, formulation, or storage. Through detailed studies, such as forced degradation experiments and stress testing, scientists gain valuable insights into the chemical stability and degradation mechanisms of leuprorelin, facilitating the design of more stable and effective pharmaceutical formulations.
Peptide Synthesis Process Optimization: During the manufacturing of leuprorelin and related peptides, the presence and behavior of impurities like Impurity H are closely monitored to optimize synthesis protocols. Process chemists analyze impurity formation at various stages of peptide assembly and purification, using the impurity as a benchmark to refine reaction conditions, purification techniques, and overall process efficiency. This iterative approach enables the reduction of unwanted byproducts, leading to higher yields and improved product quality.
Reference Material for Research and Development: As a well-characterized impurity, Leuprorelin (Leuprolide) EP Impurity H serves as a valuable reference material in academic and industrial research. Scientists investigating new peptide analogs, degradation pathways, or analytical technologies rely on such impurities to calibrate instruments, validate experimental protocols, and compare results across different laboratories. Its use enhances the credibility and reproducibility of research findings, supporting the advancement of peptide science and technology.
In summary, Leuprorelin (Leuprolide) EP Impurity H is indispensable for pharmaceutical quality control, analytical method development, impurity profiling, process optimization, and as a reference material in research and development. Its presence enables researchers and manufacturers to uphold stringent standards in peptide drug production, ensuring the integrity, reliability, and innovation of peptide-based therapeutics.
1. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
3. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
5. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More